Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

FDA A-fib meeting: FDA will host a public "think tank" meeting on the development of an atrial fibrillation registry on April 27 and 28 at its White Oak, Md., headquarters, Cardiac Electrophysiology and Monitoring Devices Branch Medical Officer Randall Brockman announced at the Boston Symposium on Atrial Fibrillation Jan. 16. The meeting is cosponsored by the Duke Cardiac Safety Research Consortium. More information will be available soon at the consortium's website, 1www.cardiac-safety.org
Advertisement

Related Content

FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry
FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry

Topics

Advertisement
UsernamePublicRestriction

Register

MT027043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel